Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-05T04:56:13.374Z Has data issue: false hasContentIssue false
  • English
  • Français

Opioid-Related Legislation in Kentucky and West Virginia: Assessing Policy Impact

Published online by Cambridge University Press:  01 January 2021

Julia F. Costich  and
Dana Quesinberry
Get access Rights & Permissions [Opens in a new window]

Abstract

Kentucky and West Virginia are among the states most severely affected by opioid poisonings and deaths. The legislatures of both states have enacted a broad range of bills intended to address related issues. We present an overview of legislation enacted in 2017 and 2018, along with an approach to analysis of practitioner response to one type of legislation.

Type
Symposium Articles
Information
Journal of Law, Medicine & Ethics , Volume 47 , Issue S2: 2018 Public Health Law Conference: Health Justice: Empowering Public Health and Advancing Health Equity , Summer 2019 , pp. 36 - 38
Copyright
Copyright © American Society of Law, Medicine and Ethics 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

National Conference of State Legislatures, Prescribing Policies: States Confront Opioid Overdose Epidemic (April 2018), available at <http://www.ncsl.org/research/health/prescribing-policies-states-confront-opioid-overdose-epidemic.aspx> (last visited March 22, 2019); see statutes catalogues at Injury Prevention Database/Opioid Abuse Prevention, available at <http://www.ncsl.org/research/health/injury-prevention-legislation-database.aspx> (last visited March 22, 2019).+(last+visited+March+22,+2019);+see+statutes+catalogues+at+Injury+Prevention+Database/Opioid+Abuse+Prevention,+available+at++(last+visited+March+22,+2019).>Google Scholar
See, e.g., National Opinion Research Council, “Drug Overdose Deaths in the United States,” available at <https://opioidmisusetool.norc.org/> (last visited March 22, 2019).+(last+visited+March+22,+2019).>Google Scholar
National Center for Health Statistics, “Provisional Drug Overdose Death Counts,” available at <https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm> (last visited March 22, 2019).+(last+visited+March+22,+2019).>Google Scholar
Dwyer-Lindgren, L. et al., “Inequalities in Life Expectancy among U.S. Counties,” JAMA Internal Medicine 177, no. 7 (2018): 1003-1011.CrossRefGoogle Scholar
Parker, A. M., Strunk, D., and Fiellin, D. A., “State Responses to the Opioid Crisis,” Journal of Law, Medicine & Ethics 46, no. 2 (2018): 367-381.CrossRefGoogle Scholar
See., e.g., Katz, J., “Why a City at the Center of the Opioid Crisis Gave Up a Tool to Fight It,” New York Times, April 27, 2018, available at <https://www.nytimes.com/interactive/2018/04/27/upshot/charleston-opioid-crisis-needle-exchange.html> (last visited March 22, 2019).+(last+visited+March+22,+2019).>Google Scholar
Gurka, K. K., Hu, H., Linn, H. I., Thompson, G. L., and Christy, D. M., “Changes in Drug-Related Fatal Overdoses Following Passage of Senate Bill 437 in West Virginia, 2001-2014: Heterogeneous Effects by Type and Combination of Opioids (abstract),” available at <https://injuryprevention.bmj.com/content/23/Suppl_1/A9.3> (last visited March 22, 2019).+(last+visited+March+22,+2019).>Google Scholar
Beletsky, L., “Using Law to Address Addiction and its Consequences,” in Integrating Responses at the Intersection of Opioid Use Disorder and Infectious Diseases Epidemics: A Workshop (National Academies Press, 2018): at 101.Google Scholar
Bohnert, A. S., Guy, G. P., and Losby, J. L., “Opioid Prescribing in the United States Before and After the Centers for Disease Control and Prevention's 2016 Opioid Guideline,” Annals of Internal Medicine 169 (2017): 367–375.CrossRefGoogle Scholar
Preliminary Data, Kentucky All-Schedule Prescription Electronic Registry, Office of Inspector General, Kentucky Cabinet for Health and Family Services, August 15, 2018.Google Scholar
Hernandez, Y., Meyers-Okhi, S., and Farkas, S.,et al., “How Massachusetts, Vermont, and New York Are Taking Action to Address the Opioid Epidemic,” American Journal of Public Health 108, no. 12 (2018): 1621-1622.CrossRefGoogle Scholar
Interfaith Center on Corporate Responsibility, “$1.3 Trillion Investor Coalition Probes Pharma on Opioid Accountability,” available at <https://www.iccr.org/13-trillion-investor-coalition-probes-pharma-opioid-accountability> (last visited March 22, 2019).+(last+visited+March+22,+2019).>Google Scholar
United States District Court for the Northern District of Illinois, “MDL 2804: National Prescription Opiate Litigation,” available at <http://www.ohnd.uscourts.gov/mdl-2804> (last visited March 22, 2019).+(last+visited+March+22,+2019).>Google Scholar
United States Department of Justice, DOJ National Health Care Fraud Takedown Results in Charges Against 601 Individuals Responsible for Over $2 Billion in Fraud Losses: Largest Health Care Fraud Enforcement Action in Department of Justice History Resulted in 76 Doctors Charged and 84 Opioid Cases Involving More Than 13 Million Illegal Dosages of Opioids, Press Release 18-866, June 28, 2018, available at <https://www.justice.gov/opa/pr/national-health-care-fraud-takedown-results-charges-against-601-individuals-responsible-over> (last visited March 22, 2019).+(last+visited+March+22,+2019).>Google Scholar
Pitt, A., Humphreys, K., and Brandeau, M. L., “Modeling Health Benefits and Harms of Public Policy Responses to the US Opioid Epidemic,” American Journal of Public Health 108, no. 10 (2018): 1394-1400.CrossRefGoogle Scholar